People with obesity also reported greater cost-related medication nonadherence than those with overweight, normal weight
WEDNESDAY, July 2, 2025 (HealthDay News) — Obesity is associated with financial hardship and food insecurity, according to a research letter published online June 24 in the Annals of Internal Medicine.
Simar S. Bajaj, from the Stanford University School of Medicine in Palo Alto, California, and colleagues examined contemporary patterns of financial burden by obesity and overweight status in a repeated cross-sectional study using publicly available data from the National Health Interview Survey 2019 to 2023.
The final sample included 143,271 adults with normal weight (18.5 kg/m2 ≤ body mass index [BMI] < 25 kg/m2), overweight (25 kg/m2 ≤ BMI < 30 kg/m2), or obesity (BMI ≥ 30 kg/m2). The researchers found that compared with those with overweight and normal weight, people with obesity were more likely to report financial hardship (14.2 versus 9.2 and 8.2 percent) and food insecurity (9.5 versus 6.0 and 5.6 percent). Obesity was associated with financial hardship and food insecurity in the first Poisson regression model. Financial hardship was 0.89 percentage points higher among people with overweight versus those with normal weight in the second model, which also adjusted for socioeconomic variables. Compared with those with normal weight, among people with obesity, financial hardship was 3.96 percentage points higher and food insecurity was 1.74 percentage points higher. Compared with those with overweight and normal weight, people with obesity reported greater cost-related medication nonadherence (9.2 versus 6.4 and 6.1 percent).
“In unadjusted and multivariable analyses, obesity was independently associated with difficulty paying medical bills, food insecurity, and skipping medication because of cost,” the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Recommendations Updated for Management of Anemia in CKD
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus
Therapies Compared for Newly Diagnosed Multiple Sclerosis
Initial Rx Length Tied to Long-Term Use of Z-Drugs
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML